Improving the efficacy of radiation treatment for cancers
Our work involves development of technologies and therapies to effectively control cancer while having low toxicity in normal tissues, via targeted therapies with decreased toxicity using radiolabeled antibodies and peptides; radioprotection via enzyme inhibitor drugs; radiosensitization of resistant cancer tissues using lipid receptor antagonists; and preventing or treating radiation-induced lymphopenia.
Latest news
Just published in @IJMS_MDPI’s Special Issue Radiation Biology & Molecular #RadiationOncology
Just published in @IJMS_MDPI‘s Special Issue Radiation Biology & Molecular #RadiationOncology: “Exploiting Radiation Induction of Antigens in #Cancer : Targeted Drug Delivery” https://www.mdpi.com/1422-0067/23/6/3041
Abhay Singh receives best oral presentation award at CBD retreat
Abhay Singh presented at the annual cancer biology division retreat 2018 and received a best oral presentation award for his outstanding presentation on “Role of radiation-induced TAF15 in lung cancer”
Dr. Abhay Singh receives Radiation Oncology seed grant
Dr. Abhay Singh received seed grant from Department of Radiation Oncology for accelerating his research on a novel radiation-inducible cancer target, TAF15
Dinesh Thotala receives the Seed Grant
Dr. Thotala received the seed grant to study the mechanisms of radiation-induced lymphopenia